DataMeds AI, Inc. (MEDS) stock
MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.74+0.10 (+15.41%)
Close on Nov 18, 2026Market cap $2.26MP/E –Yield –
DataMeds AI r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for DataMeds AI
DataMeds AI has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?